Literature DB >> 15956442

Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile toxin.

Anita P Borek1, Deborah Z Aird, Karen C Carroll.   

Abstract

We reviewed the results of repeated sample submissions within a 7-day time frame for Clostridium difficile toxin testing. A total of 2,940 samples were tested during a 3-month period using a cell culture cytotoxicity assay (CCCA). The results from all second samples (n = 1,101) were concordant with the original test result. In only two cases (0.8%; n = 247) was a third sample positive when the first two samples were negative. In this study, submission of multiple samples for CCCA did not increase detection of Clostridium difficile infection.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15956442      PMCID： PMC1151944          DOI： 10.1128/JCM.43.6.2994-2995.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

Review 1.  Clinical practice. Antibiotic-associated diarrhea.

Authors:  John G Bartlett
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

Review 2.  Clostridium difficile--associated diarrhea.

Authors:  S Johnson; D N Gerding
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

Review 3.  Clostridium difficile.

Authors:  Bethan Stoddart; Mark H Wilcox
Journal:  Curr Opin Infect Dis       Date:  2002-10       Impact factor: 4.915

Review 4.  Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee.

Authors:  R Fekety
Journal:  Am J Gastroenterol       Date:  1997-05       Impact factor: 10.864

Review 5.  Clostridium difficile--Associated diarrhea: A review.

Authors:  E Mylonakis; E T Ryan; S B Calderwood
Journal:  Arch Intern Med       Date:  2001-02-26

Review 6.  Clostridium difficile-associated diarrhea and colitis.

Authors:  D N Gerding; S Johnson; L R Peterson; M E Mulligan; J Silva
Journal:  Infect Control Hosp Epidemiol       Date:  1995-08       Impact factor: 3.254

7.  Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.

Authors:  C S Merz; C Kramer; M Forman; L Gluck; K Mills; K Senft; I Steiman; N Wallace; P Charache
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  The lack of value of repeated Clostridium difficile cytotoxicity assays.

Authors:  A A Renshaw; J M Stelling; M H Doolittle
Journal:  Arch Pathol Lab Med       Date:  1996-01       Impact factor: 5.534

9.  Clostridium difficile colitis: an efficient clinical approach to diagnosis.

Authors:  Y C Manabe; J M Vinetz; R D Moore; C Merz; P Charache; J G Bartlett
Journal:  Ann Intern Med       Date:  1995-12-01       Impact factor: 25.391
  9 in total
  12 in total

1.  Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin.

Authors:  John R Ticehurst; Deborah Z Aird; Lisa M Dam; Anita P Borek; John T Hargrove; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

Review 2.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Colitis due to Clostridium difficile toxins: underdiagnosed, highly virulent, and nosocomial.

Authors:  John S Fordtran
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-01

4.  Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.

Authors:  Carolyn D Alonso; Suzanne B Treadway; David B Hanna; Carol Ann Huff; Dionissios Neofytos; Karen C Carroll; Kieren A Marr
Journal:  Clin Infect Dis       Date:  2012-03-12       Impact factor: 9.079

5.  Clostridium difficile as a cause of acute diarrhea: a prospective study in a tertiary care center.

Authors:  Meghraj Ingle; Abhijit Deshmukh; Devendra Desai; Philip Abraham; Anand Joshi; Tarun Gupta; Camilla Rodrigues
Journal:  Indian J Gastroenterol       Date:  2013-03-24

6.  Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay.

Authors:  Elisabeth Aichinger; Cathy D Schleck; William S Harmsen; Lisa M Nyre; Robin Patel
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

7.  Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile.

Authors:  Megan E Reller; Clara A Lema; Trish M Perl; Mian Cai; Tracy L Ross; Kathleen A Speck; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

8.  Evaluation of repeat Clostridium difficile enzyme immunoassay testing.

Authors:  Diana M Cardona; Kenneth H Rand
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

9.  Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors.

Authors:  Carolyn D Alonso; Simon F Dufresne; David B Hanna; Annie-Claude Labbé; Suzanne B Treadway; Dionissios Neofytos; Sylvie Bélanger; Carol Ann Huff; Michel Laverdière; Kieren A Marr
Journal:  Biol Blood Marrow Transplant       Date:  2013-08-01       Impact factor: 5.742

10.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.